$HLYK Cashflow Statement | Understand Stock

$HLYK

$2.60 -$0.05 (1.81%) Close

$HLYK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net loss
Loss from discontinued operations
Adjustments to reconcile net loss to net cash used in operating activities:
Gain from disposal of discontinued operations
Depreciation and amortization
Change in fair value of derivative financial instruments
Impairment loss
Stock based compensation, including amortization of deferred equity compensation
Gain from expiration of liability classified equity instruments
Gain on change in fair value of derivative financial instruments
Amortization of debt discount
(Gain) loss on extinguishment of debt
Change in fair value of contingent acquisition consideration
Change in fair value of debt
Gain on sale of assets
Gain from realization of contingent sale consideration receivable
Other non-cash adjustments

Changes in operating assets and liabilities:
Accounts receivable
Inventory
Contract assets
Prepaid expenses and deposits
Prepaid expenses and other current assets
Right of use lease assets
Accounts payable and accrued expenses
Lease liability
Contract liabilities
Net cash used in continuing operating activities
Net cash used in discontinued operating activities
Net cash used in operating activities
Cash Flows from Investing Activities
Acquisition, net of cash acquired
Payment of contingent acquisition consideration
Proceeds from sale of discontinued operations
Proceeds from sale of ACO Business
Proceeds from sale of assets of BTG business
Acquisition of property and equipment
Net cash used in investing activities

Cash Flows from Financing Activities
Proceeds from sale of common stock
Proceeds from exercise of options and warrants
Proceeds from related party notes payable and advances
Repayment of related party notes payable and advances
Repurchase of treasury stock
Net cash provided by financing activities

Net increase (decrease) in cash
Cash, end of year
Net decrease in cash
Cash, beginning of period
Cash, end of period
Supplemental disclosure of cash flow information:
Cash paid during the period for interest
Schedule of non-cash investing and financing activities:
Recognition of operating lease: right of use asset and lease liability
Extinguishment of operating lease: right of use asset and lease liability
Common stock issuable issued during period
Fair value of options issued in satisfaction of common stock issuable
Fair value of warrants allocated to proceeds of related party notes payable
Fair value of beneficial conversion feature allocated to proceeds of notes payable
Fair value of warrants allocated to proceeds of third party notes payable
Fair value of derivative financial instruments allocated to proceeds of third party notes payable
Fair value of beneficial conversion feature allocated to proceeds of related party notes payable
Fair value of beneficial conversion feature allocated to proceeds of third party notes payable
Original issue discounts allocated to proceeds of notes payable
Reclassification of historical amounts recognized for beneficial conversion features
Fair value of warrants issued to extend related party debt
Principal amount of convertible notes payable to related party refinanced
Incremental fair value of convertible note payable to related party resulting from refinancing
Note payable to related party balance classified as accrued interest
Warrant liability incurred in connection with collection of contingent sale consideration receivable
Net carrying value of equity liabilities (assets) written off
Proceeds from sale of common stock under Standby Equity Purchase Agreement applied to note payable balance
Fair value of warrants allocated to proceeds of debt
Forgiveness of government loans
Incremental fair value of warrants modified to extend maturity date of convertible notes payable
Conversion of convertible note payable to common shares
Fair value of warrants issued in connection with conversion of convertible notes payable
Accrued liabilities relieved upon cashless exercise of warrants
Contingent acquisition consideration payable in common stock
Fair value of liability-classified equity instruments issued
Debt discount and original issue discount allocated to proceeds of notes payable
Fair value of shares issued to pay vendor accounts payable balance
Fair value of shares issued as purchase price consideration
Forgiveness of related party debt
Expenses paid by related party
Fair value of shares issued for equity issuance costs
Accrued interest included in fair value of note payable
Accounts payable included in principal balance of notes payable to related party
Fair value of stock options issued to reduce accounts payable
Impact on par value of common stock from reverse stock split

Comments